Cytori Therapeutics Announces Fall Medical Conference Presentation Schedule; Results from Adipose Stem Cell Preclinical Studies to be Reported.SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. -- Cytori Therapeutics, Inc. (Frankfurt:XMP (X/Open Management Protocol) A high-level network management protocol governed by X/Open. Network management software written to the XMP interface is shielded from the details of the underlying SNMP or CMIP protocols. ), announced today its Fall medical conference presentation schedule. The Company will present preclinical results on the use of adult adipose adipose /ad·i·pose/ (ad´i-pos) 1. fatty. 2. the fat present in the cells of adipose tissue. ad·i·pose adj. Of, relating to, or composed of animal fat; fatty. stem and regenerative re·gen·er·a·tive adj. 1. Of, relating to, or marked by regeneration. 2. Tending to regenerate. re·gen cells at the following meetings:
-- International Fat Applied Technology Society Conference,
Charlottesville, VA, September 10-13, 2005
Cytori will present results from a preclinical small-animal
efficacy study of adipose stem and regenerative cells for the
treatment of cardiac injury.
-- North American Spine Society, Philadelphia, PA, September 27-
October 1, 2005
Cytori will present data related to the potential application
of adipose stem and regenerative cells in degenerative disc
disease.
-- Transcatheter Cardiovascular Therapeutics Conference,
Washington, D.C., October 17-21, 2005
Cytori will present results from a randomized and blinded
large-animal preclinical study of adipose stem and
regenerative cells for the treatment of heart attack. The
animal's own stem and regenerative cells, isolated by Cytori's
unique cell processing method, were administered without cell
culture within hours of the heart attack so as to best
simulate a potential clinical setting.
-- Tissue Engineering Society International Conference, Shanghai,
P.R. China, October 22, 2005
Cytori will present preclinical data related to the angiogenic
(blood vessel forming) capability of adipose stem and
regenerative cells.
-- American Heart Association, Dallas, TX, November 13-16, 2005
Cytori will present additional data from the preclinical
small-animal efficacy study of adipose stem and regenerative
cells for the treatment of cardiac injury.
About Cytori Therapeutics Cytori Therapeutics (Frankfurt:XMP) is discovering and developing proprietary cell-based therapeutics utilizing adult stem cells Adult stem cells are undifferentiated cells found throughout the body that divide to replenish dying cells and regenerate damaged tissues. Also known as somatic (from Greek Σωματικóς, of the body derived from adipose, also known as fat tissue. The Company's investigational therapies target cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease , spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery reconstructive surgery n. Plastic surgery. reconstructive surgery, n surgery to rebuild a structure for functional or esthetic reasons. . To facilitate processing and delivery of adipose stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young , Cytori is developing its proprietary Celution(TM) system to isolate and concentrate a patient's own stem cells in approximately one hour. This system will dramatically improve the speed in which personalized, cell-based therapies can be delivered to patients. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion